Vimarsana
Biggest News Aggregation in the World

Page 4 - Sciences Group News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Sciences Group. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Sciences Group Today - Breaking & Trending Today

SMALL CAP MOVERS: MicroSalt raises £3m from tasty stock market debut - Vimarsana News

SMALL CAP MOVERS: MicroSalt raises £3m from tasty stock market debut

Rick Guiney, chief executive of MicroSalt, commented: 'We are delighted to announce our successful fundraise and admission to AIM.'

With 58% ownership of the shares, Location Sciences Group PLC (LON:LSAI) is heavily dominated by institutional owners - Vimarsana News

With 58% ownership of the shares, Location Sciences Group PLC (LON:LSAI) is heavily dominated by institutional owners

Key Insights Significantly high institutional ownership implies Location Sciences Group's stock price is sensitive to...

Source: yahoo.com
Location Sciences shares surge on Sorted reverse takeover - Vimarsana News

Location Sciences shares surge on Sorted reverse takeover

Location Sciences Group PLC on Tuesday announced plans to change its name, its CEO and its CFO after agreeing a reverse takeover of Sorted Holdings Ltd. Late on Tuesday morning in London, the stock...

GenFleet Therapeutics Announces GFH009 Granted with FDA Fast Track, Orphan Drug Designations for Treating R/R Peripheral T-cell Lymphomas and Acute Myeloid Leukemia - Vimarsana News

GenFleet Therapeutics Announces GFH009 Granted with FDA Fast Track, Orphan Drug Designations for Treating R/R Peripheral T-cell Lymphomas and Acute Myeloid Leukemia

SHANGHAI - GenFleet Therapeutics, a clinical-stage biotechnology company developing cutting-edge therapies in oncology and immunology, announced that U.S. Food and Drug Administration has recently...

GenFleet Therapeutics Announces GFH009 Granted with FDA Fast Track, Orphan Drug Designations for Treating R/R Peripheral T-cell Lymphomas and Acute Myeloid Leukemia - Vimarsana News

GenFleet Therapeutics Announces GFH009 Granted with FDA Fast Track, Orphan Drug Designations for Treating R/R Peripheral T-cell Lymphomas and Acute Myeloid Leukemia

/PRNewswire/ -- GenFleet Therapeutics, a clinical-stage biotechnology company developing cutting-edge therapies in oncology and immunology, announced that U.S....